Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
| Autor: | Havrdova, Eva, Arnold, Douglas L, Cohen, Jeffrey A, Hartung, Hans-Peter, Fox, Edward J, Giovannoni, Gavin, Schippling, Sven, Selmaj, Krzysztof W, Traboulsee, Anthony, Compston, D Alastair S, Margolin, David H, Thangavelu, Karthinathan, Rodriguez, Claudio E, Jody, Darlene, Hogan, Richard J, Xenopoulos, Panos, Panzara, Michael A, Coles, Alasdair J, CARE-MS I, CAMMS03409 Investigators |
|---|---|
| Přispěvatelé: | University of Zurich, Havrdova, Eva |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: | |
| DOI: | 10.5167/uzh-141425 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|